Symbol="ACOR"
AssetType="Common Stock"
Name="Acorda Therapeutics Inc"
Description="Acorda Therapeutics, Inc., a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company is headquartered in Ardsley, New York."
CIK="1008848"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="420 SAW MILL RIVER ROAD, ARDSLEY, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="18576600"
EBITDA="9540000"
PERatio="1.598"
PEGRatio="0.51"
BookValue="54.64"
DividendPerShare="0"
DividendYield="0"
EPS="9.36"
RevenuePerShareTTM="94.26"
ProfitMargin="-0.179"
OperatingMarginTTM="-0.188"
ReturnOnAssetsTTM="-0.0357"
ReturnOnEquityTTM="-0.269"
RevenueTTM="116914000"
GrossProfitTTM="82430000"
DilutedEPSTTM="9.36"
QuarterlyEarningsGrowthYOY="5.87"
QuarterlyRevenueGrowthYOY="-0.044"
AnalystTargetPrice="10"
TrailingPE="1.598"
ForwardPE="-"
PriceToSalesRatioTTM="0.108"
PriceToBookRatio="0.168"
EVToRevenue="1.497"
EVToEBITDA="-14.7"
Beta="1.432"
num_52WeekHigh="24.8"
num_52WeekLow="5.22"
num_50DayMovingAverage="14.87"
num_200DayMovingAverage="14.1"
SharesOutstanding="1242100"
DividendDate="2021-01-04"
ExDividendDate="None"
symbol="ACOR"
open="16.00"
high="16.20"
low="13.30"
price="14.96"
volume="17584.00"
latest_trading_day="2023-08-24"
previous_close="16.18"
change="-1.23"
change_percent="-7.5935%"
aroon_positive_momentum_days="69"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="69"
Volume_recent_avg="532763"
Change_recent_avg="0.14"
Delta_recent_avg="0.71"
Variance_recent_avg="0.35"
Change_ratio_recent_avg="0.93"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="69"
Aroon_momentum_negative="31"
image_negative_thumbnail_id_1="509"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_negative_thumbnail_id_2="1126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0159.jpeg"
image_neutral_thumbnail_id_1="583"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="684"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0024.jpeg"
image_positive_thumbnail_id_2="677"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0031.jpeg"
image_professor_thumbnail_id_1="1191"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
